Exelixis FDA approval barred until at least Jan 15, 2030
Exelixis won an appeals court ruling upholding key patents, with FDA approval barred until at least Jan 15, 2030.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Exelixis won an appeals court ruling upholding key patents, with FDA approval barred until at least Jan 15, 2030.